Hrt Financial LP Arcturus Therapeutics Holdings Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$24.35 - $44.39 $271,429 - $494,815	11,147 New	11,147 $271,000
Q4 2023 Feb 09, 2024	BUY	$17.71 - $32.97 $335,887 - $625,309	18,966 New	18,966 $597,000
Q2 2023 Aug 11, 2023	SELL	$23.94 - $32.36 $1.43 Million - $1.93 Million	-59,628 Reduced 71.84%	23,377 $670,000
Q1 2023 May 12, 2023	BUY	$14.72 - $23.97 $331,538 - $539,876	22,523 Added 37.24%	83,005 $1.99 Million
Q4 2022 Feb 10, 2023	BUY	$14.14 - $23.06 $855,215 - $1.39 Million	60,482 New	60,482 $1.03 Million
Q4 2021 Feb 14, 2022	SELL	$34.2 - $47.56 $434,613 - $604,392	-12,708 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $354,299 - $740,241	12,708 New	12,708 $607,000

177

25.7M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $455M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.